Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Extensive transcriptional responses are co-ordinated by microRNAs as revealed by Exon-Intron Split Analysis (EISA).

Pillman KA, Scheer KG, Hackett-Jones E, Saunders K, Bert AG, Toubia J, Whitfield HJ, Sapkota S, Sourdin L, Pham H, Le TD, Cursons J, Davis MJ, Gregory PA, Goodall GJ, Bracken CP.

Nucleic Acids Res. 2019 Sep 19;47(16):8606-8619. doi: 10.1093/nar/gkz664.

2.

A simple route to full structural analysis of biophosphates and their application to materials discovery.

Hill MR, Bastow TJ, Bourgeois L, Turner DR, Seeber A, McBean K, Whitfield HJ.

Dalton Trans. 2012 May 14;41(18):5497-501. doi: 10.1039/c2dt00023g. Epub 2012 Mar 19.

PMID:
22426245
3.

A new method to position and functionalize metal-organic framework crystals.

Falcaro P, Hill AJ, Nairn KM, Jasieniak J, Mardel JI, Bastow TJ, Mayo SC, Gimona M, Gomez D, Whitfield HJ, Riccò R, Patelli A, Marmiroli B, Amenitsch H, Colson T, Villanova L, Buso D.

Nat Commun. 2011;2:237. doi: 10.1038/ncomms1234.

4.

Periodic mesoporous Li(x)(Mn(1/3)Ni(1/3)Co(1/3))O2 spinel.

Hill MR, Booth J, Bourgeois L, Whitfield HJ.

Dalton Trans. 2010 Jun 14;39(22):5306-9. doi: 10.1039/c005146m. Epub 2010 May 7.

PMID:
20454709
5.

Electron diffraction and microscopy study of the structure and microstructure of the hexagonal perovskite Ba3Ti2MnO9.

Maunders C, Whitfield HJ, Hay DG, Etheridge J.

Acta Crystallogr B. 2007 Jun;63(Pt 3):390-5. Epub 2007 May 16.

PMID:
17507751
6.

CBED contrast in the lower order Laue zone.

Rossouw CJ, Maunders CJ, Whitfield HJ, Etheridge J.

Ultramicroscopy. 2006 Mar;106(4-5):439-48. Epub 2006 Jan 9.

PMID:
16459019
7.

Structure and microstructure of hexagonal Ba3Ti2RuO9 by electron diffraction and microscopy.

Maunders C, Etheridge J, Wright N, Whitfield HJ.

Acta Crystallogr B. 2005 Apr;61(Pt 2):154-9. Epub 2005 Mar 16.

PMID:
15772447
8.

Coherent inelastic scattering in Si and TiAl.

Moodie AF, Colson TA, Whitfield HJ.

Ultramicroscopy. 2004 Nov;101(2-4):247-55.

PMID:
15450670
9.

N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2.

Hardcastle IR, Arris CE, Bentley J, Boyle FT, Chen Y, Curtin NJ, Endicott JA, Gibson AE, Golding BT, Griffin RJ, Jewsbury P, Menyerol J, Mesguiche V, Newell DR, Noble ME, Pratt DJ, Wang LZ, Whitfield HJ.

J Med Chem. 2004 Jul 15;47(15):3710-22.

PMID:
15239650
10.

Facilitation of addition-elimination reactions in pyrimidines and purines using trifluoroacetic acid in trifluoroethanol.

Whitfield HJ, Griffin RJ, Hardcastle IR, Henderson A, Meneyrol J, Mesguiche V, Sayle KL, Golding BT.

Chem Commun (Camb). 2003 Nov 21;(22):2802-3.

PMID:
14651112
11.

Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor.

Davies TG, Bentley J, Arris CE, Boyle FT, Curtin NJ, Endicott JA, Gibson AE, Golding BT, Griffin RJ, Hardcastle IR, Jewsbury P, Johnson LN, Mesguiche V, Newell DR, Noble ME, Tucker JA, Wang L, Whitfield HJ.

Nat Struct Biol. 2002 Oct;9(10):745-9.

PMID:
12244298
12.

Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives.

Gibson AE, Arris CE, Bentley J, Boyle FT, Curtin NJ, Davies TG, Endicott JA, Golding BT, Grant S, Griffin RJ, Jewsbury P, Johnson LN, Mesguiche V, Newell DR, Noble ME, Tucker JA, Whitfield HJ.

J Med Chem. 2002 Aug 1;45(16):3381-93.

PMID:
12139449
13.

Energetics of nanocrystalline TiO2.

Ranade MR, Navrotsky A, Zhang HZ, Banfield JF, Elder SH, Zaban A, Borse PH, Kulkarni SK, Doran GS, Whitfield HJ.

Proc Natl Acad Sci U S A. 2002 Apr 30;99 Suppl 2:6476-81. Epub 2002 Mar 5.

14.

A study of Li2TiOSiO4 and Li2TiOGeO4 by X-ray powder and electron single-crystal diffraction, 17O MAS NMR andO K-edge and Ti L2,3-edge EELS.

Bastow TJ, Botton GA, Etheridge J, Smith ME, Whitfield HJ.

Acta Crystallogr A. 1999 Mar 1;55(Pt 2 Pt 1):127-132.

PMID:
10927242
15.

The human mineralocorticoid receptor gene promoter: its structure and expression.

Listwak SJ, Gold PW, Whitfield HJ Jr.

J Steroid Biochem Mol Biol. 1996 Aug;58(5-6):495-506.

PMID:
8918975
16.

Solid state NMR characterisation of crystalline Na2O-ZrO2-SiO2 phases.

Bastow TJ, Hobday ME, Smith ME, Whitfield HJ.

Solid State Nucl Magn Reson. 1996 Jan;5(4):293-303.

PMID:
8925259
17.

17O magic-angle spinning nuclear magnetic resonance of CaCO3.

Smith ME, Steuernagel S, Whitfield HJ.

Solid State Nucl Magn Reson. 1995 Jul;4(5):313-6.

PMID:
7583068
18.

Structural characterisation of Na2ZrO3.

Bastow TJ, Hobday ME, Smith ME, Whitfield HJ.

Solid State Nucl Magn Reson. 1994 Apr;3(2):49-57.

PMID:
7834313
19.

Differential mineralocorticoid (type 1) and glucocorticoid (type 2) receptor expression in Lewis and Fischer rats.

Smith CC, Omeljaniuk RJ, Whitfield HJ Jr, Aksentijevich S, Fellows MQ, Zelazowska E, Gold PW, Sternberg EM.

Neuroimmunomodulation. 1994 Jan;1(1):66-73.

PMID:
8528887
20.

Schizophrenic deficits: neuroleptics and the prefrontal cortex.

Jobe TH, Harrow M, Martin EM, Whitfield HJ, Sands JR.

Schizophr Bull. 1994;20(3):413-6; discussion 417-21.

PMID:
7973463
21.

Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and cortisol secretion in underweight patients.

Kling MA, Demitrack MA, Whitfield HJ Jr, Kalogeras KT, Listwak SJ, DeBellis MD, Chrousos GP, Gold PW, Brandt HA.

Neuroendocrinology. 1993 Jun;57(6):1082-91.

PMID:
8232766
22.
23.

Intrahippocampal colchicine alters hypothalamic corticotropin-releasing hormone and hippocampal steroid receptor mRNA in rat brain.

Brady LS, Lynn AB, Whitfield HJ Jr, Kim H, Herkenham M.

Neuroendocrinology. 1992 Feb;55(2):121-33.

PMID:
1320216
24.

Arthritis-susceptible Lewis rats fail to emerge from the stress hyporesponsive period.

Aksentijevich S, Whitfield HJ Jr, Young WS 3rd, Wilder RL, Chrousos GP, Gold PW, Sternberg EM.

Brain Res Dev Brain Res. 1992 Jan 17;65(1):115-8.

PMID:
1551226
26.

Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.

Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ Jr, May C, Post RM, Chrousos GP, Gold PW.

J Clin Endocrinol Metab. 1991 Feb;72(2):260-71.

PMID:
1846869
27.

Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol.

Whitfield HJ Jr, Brady LS, Smith MA, Mamalaki E, Fox RJ, Herkenham M.

Cell Mol Neurobiol. 1990 Mar;10(1):145-57.

PMID:
2334945
28.

Corticotropin-releasing hormone: from endocrinology to psychobiology.

Smith MA, Kling MA, Whitfield HJ, Brandt HA, Demitrack MA, Geracioti TD, Chrousos GP, Gold PW.

Horm Res. 1989;31(1-2):66-71. Review.

PMID:
2656470
29.

Effects of glucocorticoid antagonism with RU 486 on pituitary-adrenal function in patients with major depression: time-dependent enhancement of plasma ACTH secretion.

Kling MA, Whitfield HJ Jr, Brandt HA, Demitrack MA, Kalogeras K, Geracioti TD, Perini GI, Calabrese JR, Chrousos GP, Gold PW.

Psychopharmacol Bull. 1989;25(3):466-72.

PMID:
2560555
30.

The clinical implications of corticotropin-releasing hormone.

Gold PW, Kling MA, Whitfield HJ, Rabin D, Margioris A, Kalogeras K, Demitrack M, Loriaux DL, Chrousos GP.

Adv Exp Med Biol. 1988;245:507-19. Review. No abstract available.

PMID:
2852464
31.

Coordinate developmental regulation of high and low molecular weight mRNAs for rat insulin-like growth factor II.

Graham DE, Rechler MM, Brown AL, Frunzio R, Romanus JA, Bruni CB, Whitfield HJ, Nissley SP, Seelig S, Berry S.

Proc Natl Acad Sci U S A. 1986 Jun;83(12):4519-23.

32.

Isolation of a cDNA clone encoding rat insulin-like growth factor-II precursor.

Whitfield HJ, Bruni CB, Frunzio R, Terrell JE, Nissley SP, Rechler MM.

Nature. 1984 Nov 15-21;312(5991):277-80.

PMID:
6390212
33.
34.

Increased hexose transport in Chinese hamster ovary cells resistant to 3-O-methyl-D-glucose.

Whitfield CD, Hupe LM, Nugent C, Urbani KE, Whitfield HJ.

J Biol Chem. 1982 May 10;257(9):4902-6.

35.
38.
40.

Purification of an altered DNA polymerase from an E. coli strain with a pol mutation.

Kelley WS, Whitfield HJ.

Nature. 1971 Mar 5;230(5288):33-6. No abstract available.

PMID:
4930962
42.

Relative translation frequencies of the cistrons of the histidine operon.

Whitfield HJ Jr, Gutnick DL, Margolies MN, Martin RG, Rechler MM, Voll MJ.

J Mol Biol. 1970 Apr 14;49(1):245-9. No abstract available.

PMID:
4915861
43.

Procedure for identifying nonsense mutations.

Berkowitz D, Hushon JM, Whitfield HJ Jr, Roth J, Ames BN.

J Bacteriol. 1968 Jul;96(1):215-20.

44.

Classification of aminotransferase (C gene) mutants in the histidine operon.

Whitfield HJ Jr, Martin RG, Ames BN.

J Mol Biol. 1966 Nov 14;21(2):335-55. No abstract available.

PMID:
5339606
45.

Polarity in the histidine operon.

Martin RG, Silbert DF, Smith WE, Whitfield HJ Jr.

J Mol Biol. 1966 Nov 14;21(2):357-69. No abstract available.

PMID:
4291404
46.

Frameshift mutagenesis in Salmonella.

Ames BN, Whitfield HJ Jr.

Cold Spring Harb Symp Quant Biol. 1966;31:221-5. No abstract available.

PMID:
4866378
47.

A molecular model of the phenomenon of polarity.

Martin RG, Whitfield HJ Jr, Berkowitz DB, Voll MJ.

Cold Spring Harb Symp Quant Biol. 1966;31:215-20. No abstract available.

PMID:
4866377
48.

PARTIAL NEPHRECTOMY FOR TUMOR IN A SOLITARY KIDNEY.

ROLNICK D, WHITFIELD HJ, GROVE JS, SALEH JF, KANDEL GL.

IMJ Ill Med J. 1965 Feb;127:168-70. No abstract available.

PMID:
14270232
49.

SEDIMENTATION PROPERTIES OF THE ENZYMES OF THE HISTIDINE OPERON.

WHITFIELD HJ Jr, SMITH DW, MARTIN RG.

J Biol Chem. 1964 Oct;239:3288-91. No abstract available.

50.

Closed treatment of carcinoma of bladder.

WHITFIELD HJ.

J Natl Med Assoc. 1953 Jan;45(1):65-7. No abstract available.

Supplemental Content

Loading ...
Support Center